Riyadh – Mubasher: Dallah Healthcare Company reported its interim financial statements for the third quarter of 2019.
Net profits after zakat and tax decreased by 18.15% to SAR 26.6 million in Q3-19, compared to SAR 32.5 million in Q3-18, according to the company’s filing to the Saudi Stock Exchange (Tadawul) on Sunday.
The fall in profits was to attributed to the increase in operating cost that accompanies hiking operating levels of Namar Hospital, in addition to the increase in financing cost because of increase of operating leverage for Dallah-Namar Hospital and increase of the company’s investments.
Revenues of the Saudi healthcare provider increased by 7.26% year-on-year to SAR 301.3 million during the three-month period ended September.
For the first nine months of 2019, net profits of Dallah retreated by 29.46% to SAR 77.1 million, from SAR 109.3 million in the same period of the previous year.
The company generated SAR 908.5 million in revenues in nine months, up 5.3% from SAR 862.7 million in the corresponding period last year.
Profit per share registered SAR 1.06 by the end of September, versus SAR 1.46 in September 2018.
